Friday, 10 May 2013
A publicly-listed Melbourne-based health diagnostic company conducting researching into ovarian cancer and a number of other serious diseases has collapsed following the termination of a key funding agreement. by Yolanda Redrup
SHARE
Wednesday, 01 May 2013
Prime Minister Julia Gillard has announced the Medicare levy will rise by 0.5% in order to fund the government’s National Disability Insurance Scheme. by Patrick Stafford
SHARE
Friday, 12 April 2013
Changes to medical R&D grants could see the biotech sector shortchanged by up to $70 million. by Michelle Hammond
SHARE
Wednesday, 06 February 2013
After a torrid 2012 full of recriminations and shareholder revolt, Cochlear has hopes it has turned the corner for 2013. by Kath Walters
SHARE
Monday, 21 January 2013
The Fair Work Ombudsman has launched a compliance crackdown on the pharmacy industry. by Yolanda Redrup
SHARE
Monday, 24 December 2012
Australian firm Aesop has been snapped up by Brazilian cosmetics company Natura Cosmeticos in a deal worth $68 million. by Cara Waters
SHARE
Monday, 17 December 2012
Succession planning need not always be a drawn out, messy affair. Sometimes outside investors can provide suitable solutions. by Patrick Stafford
SHARE
Monday, 26 November 2012
The healthcare market might be booming but that has not kept Sedco from collapse. by Patrick Stafford
SHARE
Tuesday, 06 November 2012
Heard the one about the biotech company that became a coal miner? That's the innovative path Avexa have taken to capital raising. by James Thomson
SHARE